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ABSTRACT
Childhood migraine is a prevalent disorder seen in 
pediatric practice. Preliminary uncontrolled reports 
evaluating skin temperature biofeedback with autogenic 
training have suggested that it may be a useful interven­
tion for childhood migraine. The present study used a 
controlled group outcome design to further evaluate the 
effectiveness of skin temperature feedback with autogenic 
training and home practice.
Subjects were 28 children, ages 7 to 16, 14 males and 
14 females. After receiving a physician's diagnosis of 
migraine a second diagnosis of migraine was made by the 
experimenter. Children were matched by baseline headache 
intensity, sex and age and then randomly assigned to either 
a waiting-list control or treatment group.
Six dependent measures of headache activity were ob­
tained from weekly headache records that the child and 
parents kept during baseline, treatment and follow-up. 
Assessment of ability to increase skin temperature without 
feedback was made at pre- and post-treatment sessions.
The waiting-list control group attended 2 attention 
placebo sessions during the baseline period and one at the 
end of treatment. The treatment group participated in two
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pre-treatment measurement sessions and 10 treatment sessions 
with home practice. Nine sessions included analogue skin 
temperature feedback and self-control phases. The tenth 
consisted of self-control only.
Results of a 2x3 analysis of variance with one repeated 
measure found the treated group was improved significantly 
on headache index, frequency, duration, highest headache 
intensity rating and average peak headache intensity rating 
at the end of treatment as compared to the waiting-list 
control group. At the one-month follow-up these headache 
variables were still significantly improved for the treated 
group, and their medication index was also significantly 
reduced as compared to the waiting-list control group.
Analyses of the skin temperature data showed the 
treated group significantly increased skin temperature with­
out feedback at the end of treatment as compared to pre­
treatment performance, but scores were not significantly 
different from the waiting-list control group's scores.
The study is the first controlled experimental demon­
stration that skin temperature biofeedback with autogenic 
training and home practice is an effective treatment for 
childhood migraine.
INTRODUCTION
Migraine headaches are one of the most common dis­
orders seen in pediatric practice, with an incidence of 
approximately 50 cases per 1000 children or 4-5 percent 
incidence of children between ages 7 and 15 years (Bille, 
1967; Brown, 1977). The prevalence of migraine increases 
with age and is rare under 2 years of age. Before puberty, 
the prevalence of migraine is equivalent for males and 
females. After puberty, the ratio changes with more women 
reported than men as migraneurs (Waters & O'Connor, 1975; 
Thompson, 1980).
Williamson (1981) has noted that although migraine 
headaches have generally been considered a clinical problem 
of interest to the medical profession, in recent years more 
physicians and psychologists think of most headaches to be 
of psychological origin. Behaviorally oriented psycholo­
gists have begun to successfully apply behavioral principles 
to the assessment and treatment of headaches. They have 
also contributed theories concerning the development and 
maintenance of migraine headache. There is an extensive 
literature concerning etiology and treatment of headaches 
with adults, especially migraneurs. However there are 
relatively few studies of headaches in children (Brown,
1977; Thompson, 1980). Thus much of the information on 
headache symptomology, pathophysiology and treatment pre­
sented in this paper is based on research with adults.
Clinical Symptomology
Migraine headache, as proposed by the Ad Hoc Committee 
of the classification of headaches (1962), has two diagnos­
tic categories, classic and common. In the classic form 
the headache consists of three phases. During the first 
phase, prodromal symptoms are usually reported. Prodromal 
symptoms usually occur between 10 and 30 minutes before 
onset of the headache. Common prodromes are scotomata, 
flashing lights, fortification spectra, abdominal pain, 
vertigo and parathesias of the face or hands (Williamson, 
1981; Prensky & Sommer, 1979). Many nonspecific changes 
may occur in the prodromal phase. In children, specifically, 
increases in bedwetting, nightmares, somnabulism and sleep 
disturbances may precede the headache (Thompson, 1980).
During the second phase, the migraine headache occurs. 
The headache phase is characterized by the onset of throb­
bing or pulsating, unilateral pain. The pain occurs most 
often in the temporal, orbital, supra-orbital or occipital 
cranial regions. Head pain is usually accompanied by 
nausea, photophobia, and constipation or diarrhea. Local 
edema often results around the affected area of the head. 
Edema exacerbates the pain and may leave the area sensitive 
after the headache has ended. In the final phase, post­
headache, most children report a feeling of exhaustion.
3Some are very talkative and occasionally euphoric. Those 
who retain fluid during an attack may experience polyuria 
(Thompson, 1980).
Common migraine headache is similar to classic migraine 
except pain is not well localized and often has a bilateral 
location. Prodromal symptoms are not experienced and head­
aches tend to be somewhat longer (Adams, Feuerstein &
Fowler, 1980).
Congden and Forsythe (1977) have noted that no one 
definition of childhood migraine has gained universal accept­
ance. Prensky and Sommer (1979) have enumerated criteria 
that they believe are suitable for diagnosis in children.
The criteria suggested by Prensky and Sommer are often used 
for studies of children with migraine headaches (Congden & 
Forsythe, 1979; Jay & Tomasi, 1981). Their criteria are 
similar to those suggested by the Ad Hoc Committee on the 
Classification of Headache (1962). Prensky and Sommer 
specify that the headaches must be separated by symptom- 
free periods and insist that at least three of the following 
six symptoms occur: 1) nausea and vomiting, 2) unilateral
pain or hemicrania, 3) pulsating pain, 4) relief after rest, 
5) visual, sensory or motor prodromes and 6) history of 
migraine in immediate family. Using the six symptoms as 
criteria, both common and classic migraine types are in­
cluded. Prensky and Sommer's diagnostic criteria were 
used in defining the subject population for the present 
s tudy.
The frequency of migraine occurrence may vary widely 
from individual to individual, but at least one episode 
per month has often been reported for children (Bille,
1967). There is evidence that migraine headache episodes 
are generally shorter in children, usually lasting an hour 
or more, but rarely longer than 12 hours (Vahlquist & 
Hackzell, 1949; Bille, 1967).
Pathophysiology
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Neurological, biochemical and vascular mechanisms 
have been implicated in the pathophysiology of migraine 
headaches. It appears that migraine patients may be charac­
terized by greater reactivity of autonomic responses, espe­
cially with increased cephalic vasoactivity. A variety of 
biochemical mechanisms have been proposed to explain the 
increased vasoactivity that has been demonstrated in cere­
bral and systemic blood vessels. No one theory explains 
all the phenomena of migraine, but considerable advances 
have been made during the past 20 years. Research has been 
difficult in the area of migraine because it is a transient 
functional disorder that leaves no permanent structural 
change after the headache. Furthermore, animal experimen­
tation is not readily applicable to the problem (Diamond & 
Dalessio, 1978; Walshe, 1969).
Neurological Pain Pathways
Neurological pain pathways for pain sensitive areas of 
the head have been established (Diamond & Dalessio, 1978). 
Structures included are the arteries, muscles, scalp and
skin of the head. For pain in the frontal, temporal or 
parietal areas, the trigeminal nerve is thought to be in­
volved. The glossopharnyngeal and vagal nerves are involved 
in pain of the occipital region.
Hormonal Theories
Migraine in females frequently begins at menarche, 
improves during pregnancy, is aggravated by oral contracep­
tives and disappears with menopause (Whitty, Hockady & 
Whitty, 1966). In males, migraine frequently improves dur­
ing adolescence. Observations such as these imply involve­
ment of sexual hormones, e.g., estrogen, progesterone and 
perhaps prolactin (Wainscott, ref. note 1). Brown (1977) 
suggests normal hormonal changes influence the occurrence 
of headaches in the generally predisposed individual. 
Dennerstein, Toby, Burrows and Hyman (1970) report migraine 
frequently increases with decreasing serum estrogen levels. 
Graham (1981) hypotheses that histamine as well as anti­
histamines are increased as a result of hormones during 
pregnancy. And alternative hypothesis to a direct effect 
is offered by Stein (1980) who suggests that hormones may 
act indirectly influencing the metabolism of vasodilating 
substances such as serotonin. There are several theories 
describing the role hormones may play in causing, predis­
posing or diminishing migraine. No one theory has been 
adequately researched, thus it is difficult to draw conclu­
sions on the biochemical influence hormones have on the 
production of migraine headaches.
Biochemical Theories
Vasoactive amines have been implicated in the patho­
genesis of migraine (Thompson, 1980). Some patients report 
the onset of headache after ingestion of cheese or chocolate, 
suggesting an effect of tyramine and plenylethylamine, 
respectively, on blood vessels sensitive to these substances 
(Harrington & Harper, 1967). Experimental studies in which 
migraine patients have been given tyramine have produced 
conflicting results (Brown, 1977).
Another biochemical theory suggests that changes in 
platelet aggregation and the blood clotting systems play a 
role in the migraine attack (Appenzeller, 1969). Platelet 
aggregation is increased during the prodrome and decreased 
during the headache. Serotonin, a vasoconstrictor, induces 
platelet aggregation and platelet serotonin is rapidly metabo­
lized, resulting in vasodilation of scalp vessels secondary 
to withdrawal from its vasotonic effects (Lance, Anthony,
& Hinterberger, 1969; Freidman, 1978). One problem with 
this theory is that serotonin could be secondary to changes 
in platelet aggregation, because the serotonin that is re­
leased is already contained in the platelets (Diamond & 
Dalessio, 1978). The serotonin hypothesis also fails to 
explain the unilaterality and periodicity of migraine.
There is limited experimental support for this theory.
Studies on the action of serotonin on intra- and extra- 
cranial blood flow in humans and animal research have been 
conflictual (Adams et al., 1980). Two studies using migraine
patients found that intra-cranial injection of serotonin 
had little effect on the calibar of intra-cranial arteries 
(Lance, Anthony 6c Gonski, 1967). Lance et al. did find 
vasoconstriction of the external carotid with injections 
of serotonin. Studies investigating the effects of intra­
carotid injection of serotonin with animals reported results 
conflicting with the Lance et al. studies. In the animal 
studies, constriction of both intra- and extra-cranial 
arteries resulted with injection of serotonin (Welsh, Haski,
& Meyer, 1 9 7 3 ;  Welsh, Spira, Knowles, 6c Lance, 1 9 7 4 ) .  
Hemodynamic Theories
Hemodynamic studies support Wolff's (1963) classic 
theory of migraine. Wolff describes three phases of migraine 
characterized by vascular changes. In the first phase, pre­
headache, constriction of intra- and extra-cranial arteries 
occurs. This reduction of blood supply was thought to 
cause prodromal symptoms. Most hemodynamic studies 
have reported that during the pre-headache phase, intra­
cranial and extra-cranial vasoconstriction occurs. Skinhoj 
(1973) reported approximately 20-50% reduction of intra­
cranial blood flow that is usually most pronounced in the 
cortical areas associated with prodromal symptoms of classic 
migraine patients. Presently, medical researchers have not 
firmly established the reasons for the absence of prodromes 
in common migraine. Recent evidence indicates common and 
classical migraine headache may differ due to degree of vaso­
spasm or differing metabolic demands of the brain (O'Brien, 
1971).
Wolff contended that the headache phase was caused by 
vasodilation of the internal and external carotids. Head­
ache pain results from increased tension within or about 
pain sensitive arterial walls due to the increased blood 
flow after vasodilation. Hemodynamic studies have found 
small increases of intra-cranial blood flow and profound 
extra-cranial vasodilation during the headache phase 
(Skinhoj, 1973).
During the post-headache phase the vascular systems, 
according to Wolff, return to preheadache conditions. 
Edmeads (1977) found that although blood supply did decreas 
during the preheadache phase and increased during the head­
ache phase, vascular changes did not correlate precisely 
with occurrence of symptoms features. Diamond and Delassio 
(1978) suggest Wolff's theory gives a good description of 
vascular changes but is inadequate in explaining the 
etiology of migraine.
Unified Theory of Migraine
Biochemical, neurological and vascular theories to 
date do not give a comprehensive explanation of the phenome 
non of common and classical migraine. What is important to 
note is extra-cranial vasodilation does not invariably pro­
duce headache. Thus an adequate theory must be able to 
explain the simultaneous vascular and humoral changes that 
result in a sterile inflamation and a unilateral vasospasm 
of the intra-cranial and extra-cranial arteries. Diamond 
and Dalessio (1978) have formulated a unified theory of
migraine which presently is the best integrated theory of 
the pathophysiology of migraine.
Diamond and Dalessio contend that migraine must be 
understood in terms of three parallel response systems, 
vascular, biochemical and subjective/behavioral. Unlike 
Wolff and others they discuss only two phases, pre-headache 
and headache.
Diamond and Dalessio adopt Oleson's (1972) theory of 
cerebral blood supply control mechanisms to explain the 
vascular changes during migraine attacks. Oleson proposed 
two vascular systems which control blood flow within the 
cerebrum. The first system, the "innervated cerebral 
vascular system" consists of pial and large arteries at the 
base of the brain. Adrenergic nerve fibers innervate this 
system. The "innervated cerebral vascular system” is 
responsive to external or non-local influences. Diamond 
and Dalessio suggest that an external event, particularly 
a stressful one, can cause vasoconstriction of the arteries 
of this system.
The second system is called the "non-innervated cere­
bral system." It consists of parenchymal vessels which 
mostly respond to local metabolic needs of brain tissues. 
This second system is unresponsive to external events and 
non-local influences because it is not innervated by 
adrenergic nerve fibers.
Diamond and Dalessio postulate that during the pre­
headache phase, the innervated cerebral vascular system
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constricts creating a reduction in blood flow resulting in 
hypoxia and cerebral acidosis. Classic migraine patients 
may experience focal neurological symptoms or prodromes at 
the subjective/behavioral level. In response to these 
vascular changes the non-innervated cerebral vascular system 
will vasodilate to meet the metabolic needs of local brain 
tissue. The large extra-cranial arteries will also become 
dilated to increase the intra-cranial blood flow if sus-
i
tained intracranial vasodilation is required. Wolff (1963) 
and Dalessio (1972) suggest that a defective neurogenic 
mechanism, an abnormal extracranial vasomotor response, may 
be characteristic of individuals susceptible to migraine. 
This "over-reaction" to intra-cranial vasoconstriction re­
sults in excessive vasodilation of extra-cranial arteries. 
Massive vasodilation of extra-cranial arteries results in 
release of histamine and peptide kinins as well as mechani­
cal stimulation of free nerve endings. During the headache 
phase, extreme vasodilation and liberation of histamine and 
peptide kinins result in sterile inflamation and local edema 
and the behavioral experience of pulsating pain.
This theory stresses the dysregulation of cephalic 
blood flow rather than serotonin, histamine and other vaso­
active substances. Diamond and Dalessio's position is quite 
a contrast to other theories discussed such as Appenzeller1s 
(1969) and Wolff's (1963). No one theory is supported more 
than the other by research in the field. However, Diamond 
and Dalessio present the best integration of existing data
pertaining to migraine pathophysiology. What is important 
about the unified theory of migraine is that although they 
do not elaborate on environmental, behavioral and cognitive 
factors, Diamond and Dalessio do recognize that these fac­
tors may play a role in the development of migraine.
Treatment of Migraine Headache
Adult Studies
Although this particular study was concerned with 
children who have migraine headaches, a brief review of 
treatment approaches for adult migraineurs is in order, 
especially since treatment research concerning children is 
scant. Traditional medical procedures can be classified 
as abortive, prophylactic, palliative or surgical. Abor­
tive and prophylactic treatments can be effective in al­
leviating migraine headaches. However, abortive or 
prophylactic medication may result in serious side effects. 
For instance, with an abortive medication such as ergotamine 
tartrate, nausea, vomiting, diarrhea, drowsiness and cramp­
ing may result. Development of tolerance to medications 
used as a preventive measure, e.g., ergotamine and methy- 
sergide, may occur and create withdrawal symptoms, (Lucas 
& Falkowski, 1973). Palliative treatment, usually narcotic 
medications, may be helpful but varies on an individual 
basis and abuse of narcotics is possible. Surgical inter­
ventions have not proven to be adequately beneficial to 
warrant permanent structural damage (Adams et al., 1980). 
Because of the harmful short and long term side-effects
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and variable success of medical approaches, behavior therapy 
has developed a variety of behavioral interventions for the 
treatment of migraine headaches.
Four behavioral interventions have been found to be 
more effective than no treatment control conditions. These 
treatment procedures are skin temperature biofeedback with 
autogenic training, relaxation training, cephalic vasomotor 
biofeedback and behavioral self-management. No one treat­
ment has been shown to be more effective than the others. 
Controlled outcome studies have reported that between 407> 
and 1007o of adult patients have improved after treatment.
Skin temperature biofeedback with autogenic training.
Skin temperature biofeedback with autogenic training was 
one of the first behavioral interventions to be studied.
Skin temperature biofeedback involves instructing the pa­
tients to raise their skin temperature, usually of their 
index finger or hand. Feedback can be in the form of visual 
or auditory signals, which change as a function of changes 
in skin temperature. Within each session, after a pre­
determined time, feedback is often withheld and the patient 
is asked to continue to raise his or her skin temperature.
This treatment phase is usually called self-control. Skin 
temperature feedback is usually combined with autogenic 
training. This component is used to help patients 'warm 
their hands and relax further. Autogenic training consists of 
having the patient imagine various sensations and instructing 
how to relax muscles. For instance, the patient is instructed
to imagine his or her hand becoming heavy and warm. Once 
the patient achieves the feeling of warmth and heaviness, 
he or she then concentrates on breathing and heart rate, 
imagining that heart rate and breathing are regular and 
calm.
Several early reports indicated that skin temperature 
feedback was effective with migraine headaches (Sargent, 
Green, 5c Walters, 1972; Mitch, McGardy, 6c Iannone, 1976; 
Solback 6c Sargent, 1977; Sovac, Kunzel, Sternback, 6c 
Dalessio, 1978). Early studies were promising but outcome 
data were subjective and they lacked experimental control 
groups. More recently, a controlled group outcome study 
with one year follow-up data has been reported (Blanchard, 
Theobald, Williamson, Silver, 6c Brown, 1978; Silver, 
Blanchard, Williamson, Theobald, 6c Brown, 1979) . Skin 
temperature biofeedback with autogenic training was found 
to be superior to a waiting-list control that monitored 
headache activity. In addition, at the end of treatment 
54% of the subjects were either headache free or much im­
proved (as defined by 50% reduction of headache frequency 
or intensity). At a three-month follow-up success was 40% 
and this improvement was maintained at one year follow-up.
Several studies using skin temperature biofeedback 
without autogenic training have shown skin temperature 
feedback to reduce headache activity (Johnson 6c Turin, 1975; 
Turin 6c Johnson, 1976; Wickramasekera, 1973; Reading 6c Mohr, 
1976). One controlled group outcome study by Mullinix,
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Norton, Hack, and Fishman (1978) compared one group receiv­
ing true skin temperature feedback to one receiving false 
skin temperature feedback. The true feedback group increased 
temperature better than the false feedback group, but there 
were no differences between the groups on headache measures. 
Headache activity for both groups was decreased. Thus it is 
not clear whether improvements were due to experimental or 
placebo effects (Williamson, 1981).
Psychophysiological explanations for the effectiveness 
of skin temperature biofeedback have been of two kinds. 
Sargent et al. (1972, 1973) first explained the phenomenon 
in terms of modifying peripheral and cephalic vasomotor 
responses. Initially he thought that as peripheral vaso­
dilation from hand warming occurred that cephalic vaso­
constriction would occur. Recent studies do not support 
Sargent's hemodynamic theory (Price & Tursky, 1976; Sovack 
et al., 1978). Results of recent skin temperature feedback 
studies showed for most cases cephalic vasodilation occurred 
with peripheral vasodilation during hand warming. However, 
for some of the subjects in the Sovack et al. study, cephalic 
vasoconstriction occurred. Sovack et al. hypothesized that 
skin temperature feedback was effective because it produced 
a general decrease of sympathetic arousal.
Cinciripini, Williamson and Epstein (1981) have pro­
vided an alternate explanation in which they hypothesize 
skin temperature training procedures produce effects counter­
acting the intra-cranial vasoconstriction of the preheadache
phase. Counteracting the initial vasoconstriction would 
reduce the vasodilation of the rebound effect of the head­
ache phase. Support for either of the two theories of the 
physiological mechanisms underlying the effectiveness of 
skin temperature feedback have been minimal. Further re­
search is warranted before either of these models can be 
accepted or rejected.
Relaxation training. Relaxation training has been 
used for the treatment of migraine headache in six studies 
(Lutker, 1 9 7 1 ;  Hay & Madden, 1 9 7 1 ;  Paulley & Haskell, 19 7 5 ;  
Warner 5c Lance, 1 9 7 5 ;  Benson, Klemchuk, 6c Graham, 1 9 7 4 ;  
Blanchard et al., 1 9 7 8 ) .  With the exception of Benson et al.'s 
study, shortened versions of Jacobson's (1938) progressive relaxa­
tion procedure have been employed. Exercises consist of 
instructing the patient to tighten then relax various 
muscle groups of the body. Between exercises, suggestions 
of heaviness, warmth and looseness are given to the patient. 
As patients become more able to relax their muscles, muscle 
groups become combined and the number of muscle groups is 
reduced. As treatment comes to an end, relaxation by recall 
for use in the natural environment is faded in. Patients 
are often given tapes of the relaxation procedure to assist 
in practice at home.
Five of the six studies mentioned lack proper experi­
mental control groups and objective outcome data. The 
sixth (Blanchard et al., 1 9 7 8 )  was a controlled group out­
come study which evaluated progressive muscle relaxation
and compared it to autogenic feedback and a waiting-list 
control group. Blanchard et al. found relaxation training 
to be significantly more effective than no treatment and 
equivalent in effectiveness to autogenic feedback. At the 
end of treatment 88% of the subjects were much improved or 
headache free. At a 3-month follow-up the success rate 
was 567o and treatment gains were maintained at one-year 
follow-up (Silver et al., 1979). At this time, relaxation 
training appears to be an effective treatment for migraine 
headache. Blanchard et al.'s study also indicates that 
relaxation training and skin temperature feedback with 
autogenic training have similar effects on headache activity 
Silver and Blanchard (1978) suggest that these interventions 
may be operating via the same psychophysiological mechanisms 
reduced sympathetic arousal.
Cephalic vasomotor biofeedback. Cephalic vasomotor 
biofeedback for training in vasoconstriction of extra- 
cranial arteries would seem to be a reasonable intervention 
since migraine headache is caused by vasodilation of extra- 
cranial arteries and vasoconstrictive medication such as 
ergotamine tartrate can alleviate head pain. Studies of 
cephalic vasomotor biofeedback have used similar methodology 
For the majority of the studies only cephalic vasomotor 
feedback (CVM) was given. In order to record CVM, sensors 
for the vasomotor response are usually placed on the right 
zygomaticofacial branch of the superficial temporal artery.
A few studies have used electromygraphic (EMG) feedback
along with CVM feedback or have given sessions of EMG feed­
back interspersed between sessions of CVM feedback. EMG 
feedback gives feedback of local muscle tension. The 
frontalis muscle region is usually the site used for EMG 
feedback. During a feedback session the patient is pro­
vided with contingent binary feedback.
Six studies examining the effects of cephalic vasomotor 
biofeedback have reported success with migraine headaches 
(Feuerstein, Adams, & Beiman, 1976; Sturgis, Tollison, 6t 
Adams, 1978; Feuerstein 6c Adams, 1977; Friar 6c Beatty, 1976; 
Bild 6c Adams, 1980; Cohen, McArthur, 6c Rickies, 1980).
Three of the studies were multiple-baseline designs and two 
were controlled group outcome studies. The first controlled 
group outcome study compared a placebo condition to cephalic 
vasomotor biofeedback (Friar 6c Beatty, 1976) . Results found 
cephalic vasomotor biofeedback to be superior to the placebo 
conditions. The second controlled group outcome study com­
pared cephalic vasomotor response feedback, EMG biofeedback 
and a waiting-list control (Bild 6c Adams, 1980). EMG bio­
feedback reduced headache frequency and duration by 50% for 
at least 50% of the treated subjects, which was not signifi­
cantly different from the control group. Cephalic vasomotor 
biofeedback was more effective than the control procedure 
and was successful in reducing headache frequency and dura­
tion by at least 50% for 86% of the treated subjects. 
Cephalic vasomotor feedback produced greater changes than 
EMG feedback but these differences were not significant.
Cohen et al. (1980) compared four biofeedback treatments 
for headache. The four feedback modalities were forehead 
skin temperature, frontalis EMG, alpha waves and vasomotor 
response of the temporal scalp arteries. A group compari­
son found that all patients demonstrated a significant 
reduction in number of headaches per week with no change 
in intensity, disability or length of headaches. Cephalic 
vasomotor feedback was as effective as skin temperature,
EMG and alpha wave feedback.
Cephalic vasomotor biofeedback, as evidenced from the 
controlled group studies, appears to be a viable and more 
effective treatment for migraine headache patients than no 
treatment. Also cephalic vasomotor feedback is as success­
ful as skin temperature feedback, EMG feedback and relaxa­
tion training in the treatment of migraine headaches.
It is interesting to note relaxation training and skin 
temperature feedback procedures, both thought to produce 
cephalic vasodilation, have equal success rates to cephalic 
vasomotor feedback which produces the opposite effect of 
vasoconstriction. It is possible that psychophysiological 
effects of cephalic vasomotor feedback are different from 
relaxation training and skin temperature feedback. Cephalic 
vasomotor feedback may be effective in aborting or reducing 
head pain when vasodilation occurs. Relaxation training 
and skin temperature feedback, on the other hand, may be 
effective in reducing or aborting head pain by vasodilation 
during the preheadache phase or by reducing general sympathe­
tic arousal (Williamson, 1981).
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Cohen et al. (1980) in their comparison of four bio­
feedback procedures, including skin temperature feedback 
and cephalic vasomotor feedback recorded physiological data 
throughout the study. Psychophysiological changes noted 
were consistently small and unrelated to headache outcome. 
Cohen et al. conclude the effectiveness of the biofeedback 
procedures were similar and they attribute the success to 
a nonspecific one such as a relaxation phenomenon or cogni­
tive restructuring of perceived self-control. Thus cephalic 
vasomotor feedback, although seemingly producing a potent 
vasoconstriction response effect, may be successful because 
of its relaxation effect.
In summary, biofeedback and relaxation approaches to 
migraine headaches appear to be equally efficacious with 
adult migraine subjects. Although only one or two controlled 
group outcome studies have been reported for each interven­
tion, results are promising for behavioral approaches to 
migraine. Replication of the controlled group outcome 
studies is in order. Component analysis of treatment inter­
ventions would be informative, especially for autogenic 
feedback. Further studies including placebo conditions and 
false-feedback versus true-feedback needs to be conducted. 
Physiological mechanisms influenced by feedback and relaxa­
tion procedures are not well understood and basic research 
on this issue is needed.
Self-management procedures. A fourth type of inter­
vention that has been reported to be successful with migraine
patients is a comprehensive behavioral self-management 
package (Mitchell & Mitchell, 1971). Mitchell and White 
(1977) used a dismantling design to assess the contributions 
of various elements of the program which included self­
monitoring of headache activity, relaxation, self- 
desensitization and self-management skills, such as 
thought-stopping and assertion training. Self-monitoring 
of headache activity had no effect on headache pain. Re­
laxation training and self-desensitization resulted in 50% 
reduction of headache frequency with 70.4% of the subjects 
so improved. The addition of other self-management skills 
produced even further reduction of headache activity for 
100% of the treated subjects. Improvements were maintained 
at a 3-month follow-up. The results of the self-management 
program are better than those reported for other behavioral 
interventions. More research is needed in this area, in­
cluding replication and component analysis, as well as com­
parison to biofeedback techniques and relaxation alone.
Child Studies
Traditional treatment of children with migraine head­
aches has followed one of two approaches. The first and 
most common treatment method is via drugs as a prophylactic, 
abortive or palliative agent. Brown (1977) has recommended 
that drug therapy on a regular basis should be reserved for 
those children who have frequent and severe attacks that 
seriously interfere with normal functioning. For nausea 
or vomiting, prochlopezine (Stemetil) has been found to be
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helpful. For severe migraine, preparations of ergotamine 
tartrate (Cafergot, Migril) are often used to abort the 
headache. Mild to moderate headaches can usually be 
managed by having the child rest and take aspirin or 
acetaminopen. Friedman (1967) has stressed that drug 
treatment of headache symptoms requires the utmost prudence, 
particularly for children, because their response to drugs 
is predictable only to a limited extent from adult experi­
ence. He emphasizes not only the possible toxic effects 
from continuous use of medications but also adverse psycho­
logical consequences of emphasizing only the alleviation of 
migraine headache symptoms. Drug therapy may provide 
significant alleviation of migraine headaches in some cases 
but because of side effects, particularly in long-term use, 
there is a need for other nonpharmacological treatments of 
migraine.
The second traditional type of treatment for childhood 
migraine involves play techniques. These techniques are 
usually based upon psychodynamic theories. Although play 
techniques have been reported to be successful for alleviat­
ing headaches (Adams, 1967), no objective or systematic 
studies have been reported. Therefore, the development of 
alternate, nonpharmacological interventions is needed for 
such a common, long-lasting and often debilitating disorder 
as migraines in children.
As discussed in the previous section, several behavioral 
interventions have been found to alleviate migraine headaches
in adults. It seems reasonable to suggest that these same 
interventions may be successful for childhood migraine.
Only a few behavioral interventions, i.e., skin temperature 
biofeedback, cephalic vasomotor biofeedback and contingency 
management, have been studied with children migraneurs.
Four studies have been reported using skin temperature 
biofeedback with autogenic training and home practice.
Pepper and Grossman (Ref. note 2) reported upon the success­
ful treatment of two girls, ages 9 and 13, with migraine 
headaches. Their study lacked proper experimental control 
and objective outcome data, but results indicated that this
intervention may be useful. An uncontrolled group study
(Diamond 5c Franklin, 1975) tested the efficacy of skin 
temperature and EMG biofeedback with autogenic training and 
home practice with children who had common migraine. During 
a 30-month period, 32 children, ages 9 through 18, were 
treated and results indicated a decrease in frequency and 
severity of migraines in 26 of the cases. Three children 
experienced either a decrease in frequency or severity of 
headache but not both, 2 children showed no response, and 
one was "lost to follow-up" (p. 191). No control group was
available and no systematic recording of headache variables
or follow-up data were reported. Andrasik, Blanchard,
Edlund and Rosenblum (in press) presented two case studies 
of children migraneurs using skin temperature feedback and 
autogenic training. On visual inspection of graphs of 
headache activity (intensity, frequency and headache free
days) improvements are noticeable. Both headache sufferers 
achieved improvement rates of 57% at follow-up on all 
measures of headache activity.
Labbe1 and Williamson (Ref. note 3) utilized a 
multiple-baseline across subjects design to evaluate 
temperature biofeedback with autogenic training for the 
treatment of migraine headache in three children, one girl 
(age 9) and two boys (ages 12 and 13). Baseline recording 
of headache for subjects 1, 2 and 3 were taken for 6, 7 
and 8 weeks respectively. Each child participated in ten 
treatment sessions which consisted of skin temperature 
biofeedback and self-control of skin temperature. Mean 
skin temperature across sessions showed that all three sub­
jects increased their finger temperature by an average of 
.57° Celsius during feedback and self-control phases. Self- 
report of headache frequency duration, intensity and dosage 
of medication were recorded throughout the study. Results 
indicated that the average headache rating for the week 
(headache index) was reduced after treatment. More molecu­
lar analyses of frequency, intensity, duration and medica­
tion indices found that these variables were also reduced 
after treatment and were maintained during follow-up at one 
month. Thus four studies using either single case or single 
group experimental methodology reported using skin tempera­
ture biofeedback for the treatment of childhood migraine. 
While these findings are promising, they suggest controlled 
group outcome research with this intervention is warranted
in order to rigorously evaluate its efficacy.
Ramsden, Friedman and Williamson (Ref. note 4) 
applied contingency management procedures in the treatment 
of a 6-year-old girl who had been diagnosed as having 
migraine headaches. Careful behavioral assessment suggested 
this case was best conceptualized as an operant pain case 
since headache reports occurred under only a few stimulus 
conditions, e.g. work situations, and consistently produced 
sympathy and relief from responsibilities. A multiple- 
baseline across settings design was employed, first in 
school and then at home. A substantial reduction in head 
pain reports over the 18 weeks of the study was found and 
the effects of the contingency management procedure were 
maintained at a 10-month follow-up. Ramsden et al.'s study 
is interesting because it suggests that environmental con­
sequences may be an important factor in headache reports, 
especially for children.
Only one case study using cephalic vasomotor biofeed- 
back in the treatment of migraine in an adolescent has been 
reported. Feuerstein and Adams (1977) reported 4 case 
studies using EMG feedback and cephalic vasomotor feedback, 
one of which was a fifteen-year-old girl who had migraine 
headaches. Headache frequency and duration was not altered 
by EMG feedback but both frequency and duration were 
significantly reduced during cephalic vasomotor feedback. 
Their subject was able to reduce EMG during EMG feedback 
and reduce blood volume pulse during cephalic vasomotor 
feedback.
In summary, no large-scale controlled outcome study of 
behavioral interventions with children and adolescents who 
have migraine headaches has been reported. Skin temperature 
feedback with children has been examined more than other 
interventions, and even for this technique further research 
is necessary to establish its efficacy for children who 
have migraine headaches. Shortcomings of studies to date 
include small number of subjects, lack of random assignment 
of children to groups, no control group, no daily monitoring 
of headache activity and lack of specified treatment plan.
PROBLEM
Childhood migraine is a prevalent disorder seen in 
pediatric practice. Migraine headaches can interfere with 
a child's home and school life to the point that treatment 
of this problem is often sought. Traditional medical 
treatments are available but serious side-effects may re­
sult, especially with long-term usage. Behavioral approaches 
to the treatment of migraine in adults have been successful, 
a review of the literature indicating that relaxation train­
ing, skin temperature biofeedback with autogenic training, 
cephalic vasomotor feedback with EMG feedback and self­
management procedures are more effective than no treatment 
for adult migraneurs.
Reports of behavioral approaches on the treatment of 
childhood migraine have been rare. Cephalic vasomotor and 
EMG biofeedback, contingency management and skin temperature 
feedback with autogenic training have been reported to be 
useful interventions. Studies to date have consisted mostly 
of single-case reports and one uncontrolled group study.
Of the interventions evaluated, skin temperature feedback 
with autogenic training has been investigated most frequently, 
though only one published and three unpublished studies have 
been completed. Reports are interesting and promising but
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no firm statements can be made concerning the efficacy of 
skin temperature feedback with children migraneurs from the 
uncontrolled investigations. Studies to date lacked random 
assignment to conditions, had no control groups, used small 
numbers of subjects and did not use objective outcome data. 
Positive aspects of the studies have been well-defined 
characteristics of subjects, assessment of situational 
patterning and clear descriptions of procedures. The 
clinical significance of such a problem as migraine head­
aches in children and the lack of relevant outcome data for 
behavioral treatments with this population indicate research 
in this area is needed.
The present study was designed to evaluate the effec­
tiveness of a behavioral treatment with children migraneurs. 
Skin temperature biofeedback with autogenic training and 
home practice was the intervention studied. Skin temperature 
feedback with autogenic training was chosen because it is 
a comprehensive package, has been successful with adult 
migraneurs and preliminary reports indicate that it may be 
effective with children. Markman and Gottman (1978) suggest 
when a new intervention is to be tested the first step is 
to examine the effectiveness of the program as a whole and 
if it is shown to be useful, future studies can be employed 
to dismantle the program.
The design of the present study attempted to overcome 
some of the problems which existed with studies to date. 
First, the study was a controlled group outcome study. A
waiting-list control group was compared to the treatment 
group. The control group was asked to monitor headache 
activity throughout the study and received two attention- 
placebo sessions in which baseline measures of skin 
temperature were collected. Second, subjects were randomly 
assigned to the treatment or waiting-list control group. 
Third, objective outcome data of headache activity were 
employed, similar to measures used in the Labbe' and 
Williamson (Ref. note 3) study. All children recorded 
headache activity during baseline, treatment and follow-up 
phases of the study. Fourth, besides headache activity, 
self-control of skin temperature was measured before and 
after treatment of the experimental group and the control 
group. Skin temperature assessment was done to examine 
the ability to increase skin temperature after treatment 
for the experimental group as compared to baseline and to the 
waiting-list control. Fifth, maintenance of treatment ef­
fects was assessed one month after treatment for the experi­
mental group and was also compared to the waiting-list 
control at follow-up. Sixth, a careful pre-experimental 
headache assessment was made and only those children whose 
headaches had no clear situational patterning were included 
in the study.
Two basic hypotheses were tested.
Hypothesis 1 . Those children receiving skin tempera­
ture biofeedback with autogenic training will improve 
significantly at the end of treatment and follow-up, as
compared to a waiting-list control group, on dependent 
measures of headache activity.
Hypothesis 2 . Children receiving skin temperature 
feedback will learn to increase skin temperature about 
.5° Celsius after treatment as compared to the waiting- 
list control who will not show an increase in skin tempera­
ture when asked to do so.
METHOD
Subj ects
- Children were referred by pediatricians in the community 
and solicited through an article in the newspaper. Upon 
referral, the child and at least one parent were interviewed. 
The interview was structured using the Biographical Informa­
tion Sheet and included behavioral assessment for situational 
patterning of the child's headache and the completion of the 
Headache Questionnaire by both the child and parent. The 
Biographical Information Sheet and the Headache Question­
naire were adapted from a previous questionnaire used by 
Cinciripini et al. (1981) and Blanchard et al. (1978) in 
studies of headaches. Parents and children were asked to 
sign a medical consent form. See appendices A through D for 
interview materials, medical and subject consent forms.
Thirty children were interviewed who meet the criteria 
of migraine headache. Twenty-eight of the children attended 
the first pre-treatment desensitization session. The child­
ren who attended the first session were matched on age, sex 
and baseline headache index and then randomly assigned to 
either a treatment group or waiting-list control group.
Ages of the children ranged from 7 to 16, mean age=10.82. 
Fourteen of the subjects were female and 14 were male.
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Criteria for inclusion. To be included in the study 
the child had to have received a secondary diagnosis of vas­
cular or migraine headache by a physician and report at 
least 2 migraine headaches per month and also meet three
of the following six criteria:
1) headaches are predominantly one-sided
2) headaches are usually accompanied by nausea or vomiting
3) relief after rest
4) positive family history for migraine headaches
5) pulsating or throbbing pain
6) visual, sensory or motor prodromes.
Dependent Measures
The method for computing headache data developed by 
Blanchard et al. (1978) was employed in this study. Sub­
jects were given headache booklets in which they recorded 
four times per day (breakfast, lunch, dinner and bedtime) 
the intensity of the headache on a scale from 0 to 5. The 
ratings were described as follow:
0 No headache.
1 Very mild headache, aware of it only when attending 
to it.
2 Mild headache, could be ignored at times.
3 Moderate headache, pain is noticeably present.
4 Severe headache, difficult to concentrate, can do 
undemanding tasks.
5 Extremely intense headache, incapacitated.
Subjects were asked to record during the baseline phase
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the type and quantity of all medications they took for 
headaches, as well as where and what happened after they 
reported the headaches to an adult. For the treatment and 
follow-up phases the children were not asked to record 
where and what happened after they reported the headache to 
an adult. Parents were asked to aid the children in record­
ing their headaches and not to begin use of new medications 
for the headache.
Clinical variables. Data from the headache records 
were used to generate weekly scores on several clinically 
meaningful variables. The five scores are as follows:
1) Headache per week--number of discrete daily head­
aches per week. To be scored as a headache, there had to 
be a rating of zero before and after each headache for that 
day.
2) Headache index--average headache rating for the week. 
The headache index was calculated by summing all of the rat­
ings for a week and then by dividing them by 28 or the number 
of rating intervals for that week.
3) Highest headache intensity per week--the single 
highest headache rating for the week.
4) Average peak headache intensity per week--average 
of the highest headache ratings for each discrete headache 
experienced each week.
5) Headache duration— average length of headaches of intensity 
2 or greater.
6) Medication index--the medication index was computed
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by multiplying the number of pills taken by the potency 
rating. A scale adapted from Sargent et al. (1973) for 
rating potency of medication was employed (see Appendix E).
Data on the place, time and the consequences of re­
porting headaches were reviewed and analyzed for situational 
patterning of headaches. For all the children, no obvious 
patterns for operant pain were discerned.
Appartus
All experimental sessions were conducted in a two-room 
laboratory with a one-way mirror. The subject was separated 
from the experimenter and physiological recording equipment 
in a semi-sound proof room. The fingertip temperature of 
each subject was measured using a temperature thermistor 
and a Analogue-to-Digital Converter, Med Associates (ANL-90). 
The temperature was monitored from the volar surface of the 
most distal phalange of the left index finger. Temperature 
responses were reported in degrees Celsius. Automatic count­
ing of Celsius degrees of the fingertip temperature was ac­
complished using a Med Associates printout counter. Finger­
tip temperature biofeedback was provided using a Med Asso­
ciates feedback volt meter with a full scale meter deflection 
of 7cm. Feedback sensitivity was manipulated by calibrating 
the temperature channel so that a 3.0° change produced a 
full scale deflection of the feedback needle. Also, auditory 
feedback was provided using a Med Associates voltage con­
trolled audio oscillator and amplifier (ANL-910). The 
children were given temperature bands (Biotic-Band II) for
home practice. The temperature band was used to indicate 
finger temperature. It was made of thermochromic liquid 
crystal, and wrapped around the finger. It has a range 
of 20° Fahrenheit divided into 2 degree intervals which 
are indicated on the band by printed numbers.
Procedure
A controlled group outcome design was used with each 
child being assigned to either the treatment group or the 
waiting-list control group. The length of baseline for 
both groups was four weeks. During the baseline phase, 
subjects were requested to fill out daily headache records. 
Both groups were asked to attend two pre-treatment sessions 
and one post-treatment sessions. The first pre-treatment 
session was designed to desensitize the children to the 
laboratory. It involved attaching a thermistor to the 
subject for recording fingertip skin temperature. Temper­
ature response was recorded during all sessions. The sub­
ject was asked to sit for 15 minutes without any instruc­
tions, then to relax for 15 minutes as best he or she could 
For the second pre-treatment and post-treatment sessions, 
the subject was asked to sit quietly for 15 minutes, then 
asked to try to raise finger skin temperature as best he or 
she could.
The waiting-list control group was then instructed to 
keep headache records during the next two months (the treat 
ment phase for the experimental group) and for one month 
after this phase. Two months after the treatment of the
experimental group was completed, the waiting-list control 
group was given the opportunity for treatment.
For the experimental group, each child participated in 
10 treatment sessions lasting about 40 minutes each. These 
sessions were spaced across a treatment period of 7 weeks, 
two sessions per week for the first three weeks, one per 
week for the last four weeks. The first 9 treatment 
sessions consisted of 2 phases. The first phase lasted 15 
minutes and the child was given no instructions except to 
sit quietly. The first 10 minutes of phase 1 was provided 
to allow the child to habituate to the situation and to 
adjust the physiological recording equipment. The final 5 
minutes of phase 1 was used as baseline. The second phase 
consisted of 3 minutes of self-control of skin temperature 
in the absence of feedback, 15 minutes of temperature feed­
back and 3 additional minutes of self-control of skin 
temperature in the absence of feedback. The tenth treat­
ment session consisted of 10 minutes of adaptation, 5 
minutes of baseline and 15 minutes of self-control of 
skin temperature.
For the first treatment session, the operation of the 
skin temperature feedback system was explained to the child 
and he/she was given the expectancy that learning to warm 
the hands is easy to do and will lead to improvement of 
headaches. Subjects were given autogenic training instruc­
tions indicating how to imagine their hands becoming warm 
as well as how to relax. The instructions were as follows:
"Body reactions can be produced by your brain through 
thoughts. For example, when you think you are scared of 
something you may notice that your heart begins to beat 
faster. Another example would be if you are worried about 
doing well on a test or competition you may feel funny in 
your stomach. We are going to train you to produce changes 
in the temperature in the skin of your hand. If you learn 
how to do this your headaches will become better. To do 
this, sit in a comfortable position. You can think of 
particular images--warm mittens, fireplaces, etc. (explore 
individual variations and preferences here). Think about 
these things and let the muscles in your body relax.
"You will notice that when you begin warming your skin 
temperature the needle on the meter will move to the right 
and a sound from this speaker will become higher. (The 
experimenter will demonstrate feedback devices by placing 
the thermistor first on a cool surface, for decreasing 
temperature, then by blowing on the thermistor, for increas 
ing temperature.) This lets you know you are increasing 
your skin temperature and should continue to do so.
"Don't try too hard. If you don't do it right away, 
relax and try to think of warm things and soon your hand 
will be getting warm."
For two of the children autogenic instructions did not 
produce the desired temperature increase. They were then 
instructed to focus on a certain sensation in their fingers 
such as warmth and heaviness in the hand, fingers and arm.
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The experimenter stayed in the room with each child and 
continued verbal shaping until she/he was able to produce 
increases in skin temperature.
Instructions about biofeedback and autogenic training 
were repeated during the first 4 sessions. The children 
were then briefly reminded of the tasks during the remain­
der of the sessions.
Each child was instructed to practice the autogenic 
exercises and hand warming for about 10 minutes twice 
daily at home and to keep a record of home practice in the 
headache booklet. At the fourth treatment session each 
child was given temperature bands and was instructed to 
use it during the remainder of the treatment phase and 
one-month follow-up when practicing at home. Instructions 
were as follows:
"To help your headaches go away, and not come back, 
you must practice at least twice a day for about 10 minutes. 
Do the same thing that you do when you are here. You can 
use the temperature band to let you know when your finger 
is getting warmer. Remember it is your responsibility to 
practice and it is very important to do so."
In order to increase compliance with headache self­
monitoring, all children were given a gold star for each 
headache booklet they turned in. When a child collected 
11 stars they were rewarded with a small present valued at 
about $1.50. When follow-up records were completed and 
sent in, the child's name was placed in a lottery to win 
$30.00.
RESULTS
Data Analysis
Headache variables. Dependent measures of headache 
activity were computed as described in the procedure sec­
tion. The six variables or scores of headache activity 
were: headaches per week, headache index, highest headache
intensity per week, average peak headache intensity per 
week, average length of headache of intensity of 2 or 
greater and medication index. The data from the 4 weeks 
of baseline, last 2 weeks of treatment and 4 weeks of 
follow-up were used. An average score for each phase was 
computed for each headache variable.
Data analyses examined differences in headache activ­
ity within groups over baseline, treatment and follow-up, 
as well as differences between the treatment and waiting- 
list control group at each phase. A 2x3 analysis of vari­
ance (ANOVA) with one repeated measure was employed to 
test differences between the treatment and control groups 
on the six variables at baseline, treatment and follow-up.
Post-hoc analyses of simple effects included one-way 
ANOVAs and the Newman-Keuls statistic. ANOVAs-were employed 
to determine whether groups were significantly different 
at baseline, treatment and follow-up phases for all headache
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variables. Newman-Keuls tests were used for individual group 
comparisons of headache data across phases, i.e., baseline, 
treatment and follow-up. An alpha level of p < . 0 5  was 
used for all statistical analyses.
Skin temperature data. The ability to increase skin 
temperature was examined for the control and treatment 
groups by determining the average skin temperature during 
the two phases of the pre-treatment and post-treatment meas­
urement sessions: 5 minutes of baseline and 15 minutes of
temperature self-control. The skin temperature for each 
phase was the average of 10 second interval recordings 
during each phase. Difference scores were determined for 
each subject by subtracting the baseline from the self- 
control average. Difference scores were determined for the 
pre-treatment and post-treatment sessions. A two-way 
analysis of variance with one repeated measure was used to 
analyze the difference in skin temperature change between 
the two groups,’ as a function of the treatment. Due to a 
temporary malfunctioning of the heating system, which 
created an unusually cold experimental environment, three 
children from each group were excluded in the analyses. 
Reliability Checks
Computation of headache data was independently checked 
by a second student, using a 2 0% sample that was randomly 
chosen from the headache records. One-hundred percent 
agreement was obtained for frequency of headaches, highest 
intensity per week and medication index, 98% agreement was
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obtained for headache index and average peak intensity per 
week and 93% agreement was obtained for duration of headaches.
Computation of the skin temperature data was independ­
ently checked by a second person and 1 0 0% agreement was 
obtained.
Headache Data
Results of the analyses of each headache variable will 
be discussed separately and then summarized in a section 
describing the clinical significance of the findings. Skin 
temperature data will also be presented in a separate 
section.
Headache index. The results of the analyses indicate 
that the groups did not differ on headache index during the 
baseline phase. At the end of treatment, the treated group 
differed significantly from the waiting-list control, in­
dicating substantial improvement as a function of treatment. 
The improved headache index scores of the treated group were 
maintained at the one-month follow-up. Figure 1 displays 
changes across treatment phases of the mean headache index 
for the waiting-list control group and treatment groups.
Refer to Table 1 for a summary of the statistical analyses.
As shown in Figure 1, headache index for the treated group 
was substantially reduced as a function of the skin tempera­
ture biofeedback, where as the headache index of the control 
group did not improve over the treatment or follow-up 
periods. Post-hoc comparisons of the treated group's head­
ache index at baseline, treatment and follow-up demonstrated
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Figure 1. Mean headache index scores per week for both 
skin temperature feedback and waiting-list control groups 
at baseline, treatment and one-month follow-up phases.
scores were significantly lower than baseline value at the 
end of treatment and at one-month follow-up. No difference 
between the end of treatment and follow-up headache index 
was found for the treated group, indicating the treatment 
effect was maintained. Headache index for the control group 
remained stable across all three treatment phases.
Table 1
Summary Table of Analyses of Variance 
for Headache Index
Source SS df MS F P
Between Subjects 9.80 27 _ _
Condition 2.54 1 2.54 9.07 <.005
Error b 7.26 26 .28 - -
Within Subjects 2.30 56 - - -
Trials .34 2 .17 5.67 < . 0 0 1
TrialxCondition .45 2 .23 7.67 < . 0 0 1
Error w 1.34 52 .03 - -
Total 11.93 83 — — —
Headache frequency. The results of the analyses in-
dicate that the groups did not differ on. headache frequency 
during the baseline phase. The treated group improved 
significantly at the end of treatment as compared to the 
waiting-list control group. The improved headache frequency 
of the treated group was maintained at the one-month follow- 
up. Figure 2 displays changes across treatment phases of 
the mean headache frequency scores of the waiting-list 
control and treatment groups. Refer to Table 2 for a sum­
mary of the statistical analyses.
As shown in Figure 2, headache frequency for the 
treated group was substantially reduced as a function of
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Figure 2. Mean headache frequency per week for both 
skin temperature feedback and waiting-list control 
groups at baseline, treatment and one-month follow-up 
phases.
the skin temperature biofeedback, where as the headache 
frequency of the control group did not improve over the 
treatment or follow-up periods. Post-hoc comparisons of 
the treated group at each phase of the study demonstrated 
scores at the end of treatment and at one-month follow-up 
were significantly lower than baseline values. No dif­
ference between the end of treatment and follow-up was 
found for the treated group indicating the treatment effect 
was maintained. In contrast, headache frequency for the 
control group did not change during baseline, treatment or 
follow-up.
Table 2
Summary Table of Analyses of Variance 
for Headache Frequency
Source SS df MS F P
Between Subjects 329. 85 27
Condition 26. 86 1 26.86 .48 NS
Error b 302. 99 26 50.50 - -
Within Subjects 113. 34 56 - - -
Trials 13. 50 2 6.75 4.04 <.05
TrialxCondition 1 2 .89 2 6.45 3.86 <.05
Error w 8 6 .95 52 1.55 - -
Total 443. 19 83
Headache Duration. The results of the analyses indi­
cate that the groups did not differ on headache duration 
during the baseline phase. The treated group improved and 
differed significantly in comparison to the waiting-list 
control group. Improved headache duration of the treated 
group was maintained at the one-month follow-up. Changes 
across treatment phases of the mean headache duration
scores of the waiting-list control and treatment groups 
are displayed in Figure 3. Refer to Table 3 below for a 
summary of the statistical analyses.
Table 3
Summary Table of Analyses of Variance 
for Headache Duration
Source SS df MS F P
Between Subjects 365,,12 27 _
Conditions 328,.12 1 41. 39 24.49 < . 0 0 1
Error b 536,.89 26 1 . 69 - -
Within Subjects 370.,38 56 - -
Trials 57..50 2 28. 75 6.85 <.005
TrialxConditioh 93..57 2 46. 79 11.09 < . 0 0 1
Error w 219.,31 52 4. 22 - -
Total 1235..50 83
As shown in Figure 3 headache duration for the treated 
group was substantially shortened as a function of the skin 
temperature biofeedback; in contrast the headache duration 
of the control group did not improve over the treatment or 
follow-up periods. Post-hoc comparisons of the treated 
group at baseline, treatment and follow-up indicated a 
significant reduction of headache duration at the end of 
treatment and at one-month follow-up. No difference between 
the end of treatment and follow-up headache duration was 
found for the treated group, indicating the treatment effect 
was maintained. Headache duration for the control group did 
not change across the treatment phases.
Highest Intensity Rating for the week. The results of 
the analyses indicated the groups were not different on their 
highest headache intensity rating during the baseline phase.
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Figure 3. Mean headache duration per week for both skin 
temperature feedback and waiting-list control groups at 
baseline treatment and one-month follow-up phases.
The treated group improved significantly during treatment 
as compared to the waiting-list control. The improved 
intensity ratings of the treated group were maintained at 
the one-month follow-up. Figure 4 displays changes across 
treatment phases of the mean highest intensity ratings of 
the waiting-list control and treatment groups. Table 4 
summarizes the statistical analyses.
Table 4
Summary Table of Analyses of Variance 
for Highest Intensity Rating
Source SS df MS F P
Between Subjects 115.31 27 _
Condition 48.96 1 48.96 19.20 <.001
Error b 66.35 26 2.55 - -
Within Subjects 67.96 56 - - -
Trials 21.76 2 1 0 . 8 8 22.67 <.001
TrialxCondition 21.44 2 10.72 22.23 < . 0 0 1
Error w 24.76 52 .48 - -
Total 183.27 83 — —
As shown in Figure 4, highest intensity rating for the 
control group did not improve. For the treated group, 
highest intensity rating was substantially reduced as a 
function of the skin temperature biofeedback. Post-hoc 
comparisons of the treated group's highest intensity rating 
at baseline, treatment and follow-up demonstrated scores 
were significantly lower than baseline values at the end of 
treatment and at one-month follow-up. No difference between 
the end of treatment and follow-up highest intensity ratings 
was found for the treated group. In contrast, highest 
intensity ratings for the waiting-list control group re­
mained stable across the treatment phases.
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Figure 4. Mean highest intensity rating per week for 
both skin temperature feedback and waiting-list control 
groups at baseline, treatment and one-month follow-up 
phases.
Average Peak Headache Intensity Rating. Analyses of 
the average peak intensity rating found no group differ­
ences at baseline. The treated group differed reliably 
from the waiting-list control group at the end of treatment. 
The improved average peak intensity ratings of the treated 
group were maintained at the one-month follow-up. Figure 
5 displays changes across treatment phases of the mean 
average peak headache intensity ratings of the waiting- 
list control and treatment groups. Statistical analyses 
are summarized in Table 5.
Table 5
Summary Table of Analyses of Variance 
Average Peak Intensity Rating
Source SS df MS F P
Between Subjects 85. 37 27
Condition 41. 39 1 41.39 24.49 < . 0 0 1
Error b 43. 98 26 1.69 - -
Within Subjects 52. 91 56 - - -
Trials 1 1 .84 2 5.92 11.17 <.005
TrialxCondition 13. 57 2 6.79 12.81 <. 0 0 1
Error w 27. 50 52 .53 - -
Total 138. 28 83 — —
As shown in Figure 5, average peak intensity for the 
treated group was reduced as a function of treatment where­
as the average peak intensity rating of the control group 
did not improve over the treatment or follow-up periods. 
Post-hoc comparisons of the treated group's average peak 
intensity ratings at each phase of the study indicated 
scores were significantly lower than baseline values at 
the end of treatment and at one-month follow-up. No
AV
ER
AG
E 
PE
AK
 
IN
TE
NS
IT
Y 
R
A
TI
N
G
50
4
( 3 .0 5 )
(2.87) (2 .8 4 )3
( 2 . 6 0 )
2
(1.07)
(.88)
BASELINE TREATMENT FOLLOW-UP
PHASES OF STUDY
0--------- 0 Waiting-list control
g ;____^ Skin, temperature feedback
Figure 5. Mean average peak intensity per week for 
both skin temperature feedback and waiting-list control 
groups at baseline, treatment and one-month follow-up 
phases.
difference between the end of treatment and follow-up 
average peak intensity ratings was found for the treated 
group, demonstrating the treatment effect was maintained. 
Average peak intensity ratings for the control group did 
not differ across treatment phases.
Medication index. Analyses of the medication index 
indicate the groups did not differ significantly during 
the baseline phase or at the end of treatment. The groups 
did differ significantly at the one-month follow-up phase. 
Refer to Table 6 for a summary of the statistical analyses.
Table 6
Summary Table of Analyses of Variance 
for Medication Index
Source SS df MS F P
Between Subjects 4878..71 27 __
Condition 8 8 .05 1 8 8 .05
00 NS
Error b 4790,.66 26 184. 26 - -
Within Subj ects 2025,.49 56 - -
Trials 298..55 2 149. 27 4.84 <.025
TrialxCondition 1 2 1 .54 2 60. 77 1.97 <. 2 0 0
Error w 1605..40 52 30. 87 - -
Total 6904..20 83 —
Figure 6 displays changes across treatment phases of the 
mean medication index of the waiting-list control and 
treatment groups. From a visual inspection of the medica­
tion index means for the two groups, it is clear that even 
though the treated group's medication index was higher than 
the waiting-list control at baseline it was much lower than 
the control group's medication index at the end of treatment. 
Post-hoc analyses of the data for each group across trials
M
ED
IC
AT
IO
N 
IN
D
E
X
52
(6.64)
(5 .3 4 )
( 4 . 3 0 )
(3 .4 3 )
( . 0 7 )
BASELINE TREATMENT FOLLOW-UP
PHASES OF STUDY
0--------- 0 Waiting-list control
9_________q Skin temperature feedback
Figure 6 . Mean medication index per week for both skin 
temperature feedback and waiting-list control groups at 
baseline, treatment and one-month follow-up phases.
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were made because of the noticeable difference in the treated 
group's medication use and because all other headache vari­
ables for the treated group showed a similar pattern of 
improvement at treatment and follow-up. Post-hoc comparisons 
of the treated group's medication index at baseline, treat­
ment and follow-up demonstrated medication index was sig­
nificantly lower than baseline values at the end of treatment 
and at one-month follow-up. No difference between the end 
of treatment and follow-up medication index was found for 
the treated group. In contrast, medication index for the 
control group failed to change significantly throughout the study.
Thus, although the groups were not significantly different 
at the end of treatment, the treated children still improved 
substantially in their medication usage as compared to their 
baseline behavior. This improved medication index was 
significantly different from the waiting-list group at the 
one-month follow-up.
Clinical Significance of the Results
The clinical significance of the results for the indi­
vidual subjects can be presented in terms of the percentage 
of subjects that were symptom free, improved or not improved 
at the end of treatment and follow-up. "Symptom free" was 
defined as a mean score of zero on any given headache 
variable. "Improved" was defined as half the baseline score 
for the headache variables, frequency, headache index, 
duration and medication index. For the headache variables 
highest intensity rating and average peak intensity rating,
"improved" was defined as an average rating of 3 or less. 
"Not improved" was defined as greater than half of the 
baseline score for frequency, headache index, duration and 
medication index and as a rating of 4 or higher- for high­
est intensity rating and average peak intensity rating. 
Table 7 summarizes the percentage of subjects who were 
symptom free, improved or not improved at the end of treat­
ment and follow-up phases for the treated and waiting-list 
control groups.
For the treated group greater than 90% of the subjects 
were either improved or symptom free on headache index, 
highest intensity rating and average peak intensity rating 
at the end of treatment and at follow-up. In contrast, 
none of the children in the control group were symptom free 
and 14% or less were improved at the end of treatment and 
follow-up on these same dependent variables.
Frequency of headaches for 72% of the treated group 
was improved or symptom free. The percent improved or 
symptom free increased to 93% at the one-month follow-up.
In comparison, 93% of the waiting-list control group were 
rated as unimproved at the end of treatment and at the 
one-month follow-up.
The duration of headache score was defined as the 
average length of headaches of intensity of 2 or greater. 
Thus, of the 50% of the children included in the symptom 
free percentage at the end of treatment, some children were 
still experiencing very mild headaches. At the one-month
Table 7.
Percent Symptom Free, Improved or Not Improved
Follow-Up 
Symptom Free Improved*
Treatment 
Symptom Free Improved*Headache
Variable
Headache
Index
Frequency
Highest
Intensity
Average
Peak
Duration
Medication
Index
Txt. WLC
36% 0%
36% 0%
36% 0%
36% 0%
50% 0%
79% 36%
Txt. WLC
57% 7%
36% 7%
64% 7%
64% 7%
21% 7%
21% 14%
Not 
Improved 
Txt. WLC
7% 93%
28% 93%
0% 93%
0% 93%
29% 93%
0% 50%
Txt. WLC
21% 0% 
21% 0%
21% 0%
21% 0% 
21% 0%
79% 21%
Txt. WLC
72% 14%
72% 7%
79% 14%
79% 29%
50% 14%
21% 7%
* Improved scores for frequency, headache index, duration and medication 
index were rated as improved if they were 1/2 the baseline value. For 
highest intensity and average peak intensity at score of 3 or less was 
rated as improved.
Not 
Improved 
Txt. WLC
7% 8 6%
7% 93%
0% 86%
0% 71%
29% 8 6%
0% 72%
follow-up, only 21% were symptom free. However, if improved 
children were included, 71% experienced relief in headache 
duration. For the waiting-list control group, 93% of the 
children's headache duration scores were rated as unimproved 
at the end of treatment and 8 6% were unimproved at follow-up.
It is interesting to note a large percentage of both 
groups improved on medication index, as 797o of the treated 
group and 36% of the waiting-list control group had dis­
continued use of medication at the end of treatment. How­
ever, 2 2% of the waiting-list control children who had 
improved at the end of treatment returned to baseline 
medication use at follow-up. None of the treated children 
returned to baseline medication use at the one-month follow-up
i
Skin Temperature Data
Statistical analyses of the skin temperature data 
showed that groups differed, though not significantly, at some 
phase of treatment at the .1 level. Refer to Table 8 for a summary 
table of the analyses.
Table 8
Summary Table of Analyses of Variance 
for Skin Temperature
Source SS df MS F P
Between Subjects 21.92 20 _ _
Condition .66 1 .661 .59 NS
Error b 21.26 19 1 120 - -
Within Subjects 12.87 21 - - -
Trials .57 1 .574 1.03 -
TrialxCondition 1 . 6 8 1 1.680 3.01 < • 1
Error w 10.62 19 .560 - -
Total 34.79 41 - - -
Figure 7 displays the means at pre- and post-treatment 
sessions for the two groups. To determine whether the 
groups were comparable at baseline a one-way ANOVA was 
performed. The groups did not differ significantly;
F(1,19)=2 . 90, p >  .05. Inspection of the mean skin tempera­
ture difference scores at baseline showed that the waiting- 
list control group increased their skin temperature by .48 
degrees Celsius at the pre-treatment session whereas the 
treated group's mean skin temperature difference score was 
decreased by .18. Comparison of the groups at the post­
treatment sessions was also nonsignificant; F(l,20)=.14, 
p>.05.
Further analyses comparing each group's mean skin 
temperature difference scores at pre- and post-treatment 
sessions were made. The group receiving feedback was able 
to raise their skin temperature without feedback signifi­
cantly ( p < . 0 1 ) at the end of treatment as compared to 
pre-treatment performance. The waiting-list control group's 
pre-treatment mean skin temperature difference score was 
not significantly increased as compared to post-treatment 
performance. Also, their mean skin temperature difference 
score was slightly lower at the post-treatment session.
PRE POST
SESSIONS
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0-------- 0 Skin temperature feedback
Figure 7. Mean skin temperature difference scores for 
the skin temperature feedback group and the waiting-list 
control group at pre- and post-treatment sessions.
DISCUSSION
Results of the study support the effectiveness of skin 
temperature biofeedback with autogenic training and home 
practice for the treatment of migraine headaches in child­
ren. All six headache variables improved for the treatment 
group and remained the same for the waiting-list control 
group during the treatment and follow-up phases. Medica­
tion index was not as clearly improved at the end of treat­
ment as the other headache variables. The waiting-list 
control group did not differ on the medication index at the 
end of treatment and follow-up as compared to their baseline 
medication index. The groups did not differ at the end of 
treatment, but the treated group's medication index at the 
end of treatment was significantly lower than their baseline 
scores. The treated group was significantly improved at 
the one-month follow-up for medication index as compared 
to the waiting-list control group.
The headache data suggest that skin temperature bio­
feedback improves headache in all parameters. Headache 
index, the most general headache variable, was significantly 
decreased at the end of treatment and at follow-up for the 
treated group. Children receiving skin temperature feedback 
also experienced a statistically significant reduction in
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the pain level of their headaches as both highest headache 
intensity rating and average peak headache intensity rating 
were significantly reduced at the end of treatment and at 
the one-month follow-up. The time length of headaches was 
also significantly reduced for the treated group as compared 
to the waiting-list control at the end of treatment and 
effects were maintained at the one-month follow-up. Results 
of the reduction in intensity, duration or severity of the 
headaches are similar to results evaluating the effective­
ness of skin temperature biofeedback with autogenic training 
with adult migraineurs (Blanchard et al., 1978).
The number of headaches per week was significantly re­
duced at the end of treatment and at the one-month follow-up, 
although the difference between groups for frequency of 
headaches was not as great as the reduction of the severity 
of headaches. Blanchard et al. did not find a significant 
decrease in frequency of adult headaches with skin tempera­
ture biofeedback. However, the few child studies that have 
reported using skin temperature biofeedback with autogenic 
training have all reported both a decrease in frequency and 
intensity of headaches (Diamond & Franklin, 1975; Andrasik 
et al., in press; Labbe1 5c Williamson, ref. note 1; Pepper 
5c Grossman, ref. note 2). Thus the finding of a significant 
reduction in number of headaches per week as well as a de­
creased intensity of headache is consistent with previous 
child studies in the area.
Both groups reduced medication usage at the end of
treatment and their medication scores were not significantly 
different as compared to each other. Although the groups 
were not different at the end of treatment, the treated 
group's medication index score was significantly different 
at the end of treatment as compared to their baseline usage. 
The waiting-list control group's medication index was re­
duced but not to a statistically significant degree. The 
waiting-list control group's medication usage returned to 
baseline level at follow-up. In comparison, the treated 
group's reduced medication usage was maintained at follow-up. 
Results of a decrease in medication usage is also similar 
to results of adult studies and preliminary studies with 
children in the treatment of migraine headaches.
Results of the study were not only statistically 
significant but also clinically relevant. Examination of 
percent symptom free or improved suggests that most of the 
children in the treated group experienced improvement of 
their migraine headaches. At the end of treatment only 7% 
of the waiting-list control group had spontaneously im­
proved on headache index, highest headache intensity rating, 
average peak headache intensity rating, frequency and 
duration. At follow-up 14% of the waiting-list control 
spontaneously improved on headache index, highest headache 
intensity rating and duration of headache, 7% continued to 
be improved for frequency of headaches and 29% experienced 
improvement of average peak headache intensity rating.
The modest degree of spontaneous improvement for the
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waiting-list control subjects are consistent with the 
general treatment outcome literature of studies using no­
treatment control groups (Garfield & Bergin, 1978) .
The treated group showed the greatest improvement on 
the variables concerning intensity of headaches, with 1 0 0% 
of the children either improved or symptom free at the end 
of treatment and a one-month follow-up. At the one-month 
follow-up both headache index and frequency were greatly 
improved (93%) whereas only 71% of the treated children 
experienced a reduction in duration of headache.
One clinical anecdote may be useful for understanding 
how some children were able to control headaches. Prior 
to treatment, one of the treated children experienced 
parathesias of the left side of his body during the pre­
headache phase and extreme pain (usually rated as 5) during 
the headache phase. The child required numerous visits to 
the emergency room where he usually received injections of 
demerol. Following treatment, the child successfully 
employed the hand warming technique to abort the pre-headache 
(prodromal) phase, consequently the headache phase did not 
occur. He attempted to increase his skin temperature in 
his hand for about 20 minutes whenever he felt the onset of 
parathesias, which usually began in his left toes. Several 
other children reported, with great excitement, similar 
successes in aborting or greatly decreasing head pain by 
using the hand warming procedure during the prodromal phase.
Children reported enjoying the treatment program. It
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is interesting to note that throughout the treatment ses­
sions only 5 out of 140 scheduled treatment sessions had 
to be rescheduled. High attendance rate is one indication 
that the children found the sessions to be rewarding and 
worthwhile.
One potential problem with the results of this study 
is the use of self-report data. Some may criticize the 
reliability of children reporting their own pain behavior. 
During the study, parents and children were often reminded 
of the importance of accurate and current recordings of 
headaches. Parents were asked to check daily on the child's 
headache booklet. Headache booklets were turned in on a 
weekly basis and checked by the experimenter; if headaches 
occurred, the experimenter discussed the headache with the 
child and explored how the child attempted to resolve the 
pain, e.g., hand warming, medication, sleep. Children re­
ceived a gold star for each booklet turned in and rarely 
did a child forget to do so. Prompt response in turning 
in booklets and experimenter's observation of parent's and 
child's discussion of headache activity suggest the self- 
report data was probably fairly reliable.
In summary, analyses of the headache data, observations 
by the experimenter and reports by the parents of the 
children's interest and home practice indicate the children 
were able to successfully utilize the treatment procedure 
at the clinic as well as in the home. Results of the present 
study are similar to results of studies using skin temperature
biofeedback in the treatment of migraine with adults. The 
present study also extends the findings of the Diamond and 
Franklin (1975) single group study and several case studies 
(Andrasik et al., in press; Labbe' & Williamson, ref. note 
3; Pepper 5c Grossman, ref. note 2) in that a controlled 
group outcome design was used to evaluate headache activity 
and medication intake. Because the study used a controlled 
group outcome design, it provides support for the external 
validity of the technique as an effective treatment of 
childhood migraine headaches. Of the psychological tech­
niques available today, skin temperature biofeedback with 
autogenic training has been the most widely researched 
treatment approach for childhood migraineurs. Given the 
results of the present study, one can reasonably conclude 
that it is a very effective treatment for childhood migraine. 
Replication of the present study is important for further 
support of the effectiveness of the skin temperature bio­
feedback with autogenic training in the treatment of child­
hood migraine. Future studies should focus on component 
analysis of the treatment program to elucidate which com­
ponents of the program are necessary for reducing headache 
activity.
The skin temperature data indicate that the children 
in the treated group were able to significantly increase 
their finger temperature at the end of treatment as com­
pared to their pre-treatment performance. Prior to treat­
ment the treated group decreased their average baseline
65
skin temperature by an average of .18 degrees Celsius during 
the self-control phase. At the end of treatment the child­
ren were able to increase their skin temperature by an 
average of .48 degrees Celsius with no feedback, actually 
increasing their skin temperature by .66° Celsius as com­
pared to their performance at pre-treatment. Their ability 
to increase their skin temperature with no feedback at the 
end of treatment supports the initial hypothesis that 
treated children would be able to increase their skin 
temperature by about .50° Celsius at the end of skin tempera­
ture biofeedback training.
The finding that the waiting-list control group were 
able to increase their skin temperature by .47° Celsius 
prior to treatment was unexpected. They increased skin 
temperature at the end of treatment but not significantly 
so as compared to baseline performance. The results of the 
skin temperature data raise the interesting and controver­
sial question of how is the ability to increase skin 
temperature related to headache outcome. Researchers are 
becoming more concerned with the question of the psycho- 
physiological basis of therapeutic benefits of biofeedback 
and other behavioral interventions and several interpreta­
tions have been put forth (Elmore & Tursky, 1981;
Cincirpini et al., 1981; Williamson, 1981). Given the 
number of subjects receiving feedback training and the 
limited use of psychophysiological assessment the present 
study can not adequately address the issue of the
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psychophysiological basis of the therapeutic effects of 
skin temperature biofeedback with autogenic training, 
although some speculation can be put forth.
One hypothesis is that treatment was effective because 
by using the self-control phase at the home and the clinic, 
whether or not they actually produced skin temperature 
changes, a relaxation response was induced. This relaxa­
tion response, by decreasing general sympathetic arousal 
on a daily basis, influenced headache activity. Support 
for a nonspecific effect, such as relaxation, to be the 
basis of therapeutic benefit is the Mullinix et al. (1978) 
study in which false feedback also resulted in decreased 
headache activity as well as studies comparing and finding 
similarities in the effectiveness of relaxation training 
and skin temperature feedback (Williamson, 198). Recent 
biochemical studies report findings that strengthen the 
position that biofeedback influences sympathetic adreno- 
medullary activation by reducing sympathetic tone (Mathew, 
Weinman, & Largen, 1982). Reduction in plasma catecholamines 
and platelet monoamine oxidase are thought to occur with 
biofeedback assisted relaxation. A second interpretation 
is that skin temperature biofeedback with autogenic train­
ing may be successful because of the effect it has on 
cephalic vasomotor response, particularly during the pre­
headache phase. The children who used the technique when 
they thought a headache would soon occur could often abort 
or reduce headache pain. This observation suggests the
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children may have learned to reduce cephalic vasoconstric­
tion of the pre-headache phase which led to a reduction of 
the "rebound" vasodilation of the headache phase. Skin 
temperature biofeedback, then, may have a palliative effect 
by decreasing general sympathetic arousal and/or a direct 
effect by reducing the "rebound" vasodilation of the head­
ache phase. It may be the case that the underlying bio­
chemical changes for both of these explanations is the same.
In conclusion, the skin temperature data, although not 
differentiating between groups at the post-treatment session, 
did show the treated group was able to significantly increase 
their skin temperature at the end of treatment as compared 
to pre-treatment performance. Their ability to increase 
their finger skin temperature on the average of .48° Celsius 
is consistent with adult research. There are no normative 
data on children's hand warming ability with or without 
feedback with which to compare the results of these skin 
temperature data. A study investigating normative data on 
children's hand warming ability is needed. Further studies 
investigating skin temperature feedback with children 
should replicate the procedure used to evaluate the ability 
to increase skin temperature in the absence of feedback, 
before and after treatment. To shed light on the psycho- 
physiological phenomenon associated with treatment outcome, 
further studies should include more responses in their 
psychophysiological assessment, as well as biochemical 
assessment.
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Summary
The present study attempted to address two hypotheses. 
One hypothesis stated children receiving skin temperature 
feedback would be able to raise their skin temperature by 
.5° Celsius and this would be significantly different from 
the waiting-list control group. Another hypothesis stated 
children migraineurs receiving skin temperature biofeedback 
with autogenic training and home practice would significantly 
improve on selected measures of headache activity as compared 
to a waiting-list control group.
The first hypothesis was supported in that children 
receiving skin temperature feedback training were able to 
significantly increase their finger skin temperature at the 
end of treatment as compared to baseline performance. There 
were no significant differences in the waiting-list control 
group's performance at pre- and post-treatment sessions.
Firm conclusions can not be made regarding the skin tempera­
ture data as the waiting-list control group did increase 
their temperature at pre- and post-treatment sessions and 
their skin temperature difference scores were not signifi­
cantly different from the treated group at the post-treatment 
session.
The second hypothesis was strongly supported. The 
treatment was successful as the treated group did signifi­
cantly improve on all six headache variables and the waiting- 
list control did not. Thus skin temperature biofeedback 
with autogenic training and home practice appears to be an
effective behavioral intervention for the treatment of 
childhood migraine. The present study's contribution to 
clinical psychological research is that it is the first 
controlled experimental demonstration of the effectiveness 
of skin temperature biofeedback with autogenic training 
for childhood migraine.
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Appendix A 
Biographical Information
Name: Date:
Age: Sex:
Birthdate: Race:
Grade: School:
Address: Phone Number:
1. Headaches are a problem for me. Yes No
2. I take medications for relief of head pain. Yes 
No _____
3. I have had headache problems since the age of __
5. I have been to the doctor for care of my headaches.
6. If yes, his diagnosis was _____________________________
7. What, if any, medications has he prescribed for you?
8. Have you had any of the following:
eye problem ______________
ear problem ______________
dental problem ___________
sinus problem ____________
head injury ______________
seizures _ ___________
other neurological problems ______________
If you have had any of the above, how have they been 
related to your headache?
9. Have your headaches changed in frequency, duration or 
intensity during
GIRLS-Menstruation Increase   Decrease______
BOYS-Beginning of puberty Increase _____ Decrease____
4. I have approximately headaches per month.
Yes No
77
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10. I have been under stress which may be related to my 
headache. Yes   No _____
11. Do you smoke? _____  How much? _____
12. Have you ever suffered from car sickness? Yes 
No _____
13. Have you ever suffered from high blood pressure?
Yes _____  No______
14. Do you suffer from high blood pressure? Yes 
No _____
15. Do you have a parent who suffers from headaches?
Yes _____  No______
16. Does any other family member suffer from headache? 
Yes _____  No______
17. Is there a seasonal pattern to your headache?
Yes _____  No______
If yes, when ___________________________________________
18. Do you have difficulty sleeping? Yes ______  No_ ___
If yes, please describe your difficulty.____________
19. Do you wet the bed at night after a headache?
Yes ______ No______
20. Are you involved in extra curricular activities? 
Yes ______ No______
What are they? _____________________________________
21. What kinds of grades do you make? ____________________
Do your headaches interfere with school or homework? 
Yes No
Notes or Comments:
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Does your headache occur
co >1
w
> 4! ►Jw Dd H <3s
3
H
O
CO
P
CO&
in school 1 2 3 4 5
home 1 2 3 4 5
other 1 2 3 4 5
Do headaches occur during the
morning 1 2 3 4 5
afternoon 1 2 3 4 5
sleep 1 2 3 4 5
all day 1 2 3 4 5
weekdays 1 2 3 4 5
weekends 1 2 3 4 5
certain days 1 2 3 4 5
Do headaches occur when the following
people are present
parents 1 2 3 4 5
siblings 1 2 3 4 5
friends 1 2 3 4 5
teachers 1 2 3 4 5
other 1 2 3 4 5
When at home
What is the child doing before a headache?
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
Notes or Comments:
A
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stays home from school 
does not do housework 
does not do homework
When at school
Are there certain classes the child 
reports headaches in?
What happens when the child reports a 
headache?
oi >-< co CO
w fJ fJ
> W hJ <
w oi (H < DS
2
a
H
O
co
CO
p
<1
What happens when a headache is reported?
medication is given ____________
rest
like to be alone
special requests _______________
special treats
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
rest 1 2  3 4 5
medication 1 2  3 4 5
goes home 1 2  3 4 5
does not do school work 1 2  3 4 5
Notes or Comments:
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For the next two questions please 
refer to the figures below.
1. When I get a headache, the most 
severe pain occurs in area(s)
Pi >< co ►* CO
W ►J t-J
> w § J <d
w pi H <3 !3
a
a
H
O
CO
ZD
CO 5?
2. When I get a headache, I experience
pain
only
in area(s): 
1 1 2 3 4 5
only 2 1 2 3 4 5
only 3 1 2 3 4 5
only 4 1 2 3 4 5
only 5 1 2 3 4 5
only 6 1 2 3 4 5
only 1 & 2 1 2 3 4 5
only 1 & 4 1 2 3 4 5
only 1 & 6 1 2 3 4 5
only 1, 4 & 6 1 2 3 4 5
only 2 6c 3 1 2 3 4 5
only 2 6c 5 1 2 3 4 5
only 2 , 3 6c 5 1 2 3 4 5
only 3 6c 4 1 2 3 4 5
only 1 ,  2 , 3 6c 4 1 2 3 4 5
only 1 , 2 , 3 ,  4 , '  5 6c 6 1 2 3 4 5
<0>
Appendix B
HEADACHE QUESTIONNAIRE 
Name Date
DIRECTIONS: The following statements
describe symptoms which occur with dif­
ferent types of headaches. Read each 
statement carefully and then circle the 
answer which is most correct for you.
The 5 possible answers are defined as 
follow: Always (occurs without excep­
tion) , Sometimes (occurs approximately 
half the time), Rarely (occurs only 
once in a great while) Never (absolutely 
does not occur and has not ever occurred).
1. I awaken with a headache.
2. My headache lasts less than 1 hour.
3. My headache lasts from 1 to 4 hours.
4. My headache lasts from 4 to 8 hours.
5. My headache lasts from 8 to 10 hours.
6. My headache lasts from 10 to 24 hours
7. My headache lasts for more than 24 
hours.
8. I have a headache most of the time.
9. Before or during a headache I have 
blind spots in visual field.
10. Before or during a headache I see 
stars or flashing lights.
11. Before or during a headache I have 
double vision or blurry vision.
12. Before or during a headache bright 
lights bother m e .
Pd >■< co CO
w y y y >\> W y <
w Pd H c3 H y y
y CO cy
o
CO
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
1 2 3 4 5
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13.
14.
15.
16.
17.
18.
19.
20 . 
21 .
2 2 .
23.
24.
25.
26.
27.
pi SH <*) C/3
W  W  HJ fH
>  w  S  hJ c
H  2  I—• <J J3
a  <5 h  cd hJ
2 w w  <
S 3 o
CO
Before or during a headache loud 1 2  3 4 5
noise bothers me.
Before or during a headache I be- 1 2  3 4 5
come dizzy.
Before or during a headache parts of 1 2  3 4 5
my body, eye, hand, mouth, tongue, 
are numb.
I take a prescribed medication on a 1 2  3 4 5
daily basis in order to control 
headaches.
My headache begins during the night 1 2  3 4 5
while sleeping.
My headache starts after drinking 1 2  3 4 5
coffee.
My headache starts after drinking 1 2  3 4 5
alcoholic beverages.
I experience car or motion sickness. 1 2  3 4 5
My headache improves after a period 1 2  3 4 5
of rest.
My headache begins after eating cer- 1 2  3 4 5
tain kinds of food like nuts, hot 
dogs or chocolate.
I have sudden attacks of headache. 1 2  3 4 5
My headache is worst at the end of 1 2  3 4 5
the working day.
My headache is throbbing or pulsat- 1 2  3 4 5
ing.
My headache feels like a tightness 1 2  3 4 5
or an external pressure (band-like 
or cap-like).
My headache begins on the left-hand 1 2  3 4 5
side of my head.
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28.
29.
30.
31.
32.
33.
34.
35.
Pi fH CO 
H  J  W  hJ 
> W S hJ 
W  Dd M  <1 
2 <  H D
P5 W  CO
S 23O
CO
My headache begins on the right-hand 1 2  3 4 5
side of my head.
My headache begins in my neck, 1 2  3 4 5
shoulders or the back of my head.
I have nausea and vomiting with my 1 2  3 4 5
headaches.
My headache gets worse if I cough, 1 2  3 4 5
strain, or lift objects.
My headache is better if I can 1 2  3 4 5
loosen up my neck muscles.
Aspirin, Anacin, Bufferin, Excedrin, 1 2  3 4 5
BC, Alka Seltzer, or other non- 
perscription pain medications re­
lieve my headaches.
I take a prescribed medication to 1 2  3 4 5
prevent a full blown attack of a 
headache.
My headache begins when I am relax- 1 2  3 4 5
ing or enjoying myself.
A
L
W
A
Y
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Appendix C
Research Subject's Consent Form
Dr. Donald Williamson, Elise Labbe', M.A. and their asso­
ciates are conducting a study to determine if temperature 
biofeedback and autogenic training will have the effect of 
alleviating the pain of migraine headaches in children.
If you agree to let your child participate in this study, 
the following requirements will be expected of you and your 
child.
First you and your child will be interviewed concerning the 
nature of your child's headaches, e.g., symptoms and pos­
sible causes. The amount of stress in your child's life 
and other problems or situations that may be related to the 
headache will be examined. Based upon information obtained 
in the interview, we will ask some persons to participate 
in a study to evaluate the extent to which skin temperature 
biofeedback procedure reduces headache pain.
The persons who accept our invitation to participate in the 
study will be expected to cooperate in the manner described 
below: First, each child must obtain written permission 
from his/her pediatrician. For the first four weeks, you 
will schedule two meetings with one of the members of our 
staff at a time that is mutually agreeable. During these 
meetings physiological measures of facial and arm muscle 
tension, finger skin temperature, cephalic blood flow, 
heart rate, and galvanic skin response will be recorded. 
These measurements will involve placing sensors on the 
child's arms, legs, and head to detect the various physio­
logical responses. None of these procedures involve 
methods that would be painful or would produce discomfort. 
During the first session the child will sit quietly and 
will be asked to relax. During the second session the 
child will first be asked to sit quietly and then will at­
tempt to raise his/her skin temperature.
During this initial month of the study and during the re­
mainder of the study, children will be expected to record 
a rating of their head pain four times daily, i.e., break­
fast, lunch, dinner, and bedtime. After the initial four 
weeks of the study, all children will be randomly assigned 
either to a group being treated immediately or to a waiting 
list group. For the waiting list group, children will be 
asked to wait for 8 weeks before receiving treatment and 
will meet three times with our staff to report and discuss
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headache activity. For the group that receives treatment 
immediately, children will be asked to attend two sessions 
each week for three weeks and then one session per week for 
the next four weeks. A total of ten treatment sessions 
will be required. In these sessions, a trained therapist 
will assist the child in learning skin temperature bio­
feedback. Children will also be asked to practice what
they learn at home. Participants will be expected to at­
tend three follow-up sessions at 1, 3 and 6 months after
the end of therapy.
At any time during the study, you may discuss your child's 
progress and ask any questions you may have about the 
assessment or therapy procedures. Also, you may withdraw 
your child from the study at any time.
I have read the above information. I believe I understand 
the study sufficiently to participate. Any questions I 
had have been answered to my satisfaction. I agree to 
participate in the study as indicated by signature below.
Signed, Parent 
Child
Date
Witness
Appendix D
Medical Consent Form
From: Dr. ________________________________
Date:
I have examined the patient ____________________________
and can see no medical reason that he/she should be unable 
to participate in a study to evaluate the effects of 
skin temperature biofeedback and relaxation upon migraine 
headaches. Therefore the patient has my permission to 
participate in the experiment. By giving my permission, I 
understand that I am not necessarily endorsing this type 
of therapy for headaches and I understand that I am not 
legally responsible for the conduct of the therapeutic 
methods or the outcome of treatment. If you have any 
questions regarding this study, please feel free to contact 
Dr. Donald A. Williamson at the LSU Psychology Department. 
(Telephone: 388-8745)
My diagnosis of this patient's headache is: _______________
Signature _________________________
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Appendix E
Potency Rating of Medication 
on a Seven-point Scale
1 (Over the counter drugs)
APC Nervine
Alka Seltzer Norgesic
Anacin Parafon
Aspirin Percogesics
Bufferin Persistin
Ceclar Phenaphen
Comtrex Robaxisal
Cope Sinutab
Datril Sudafed
Empirin Synalgos
Excedrin Tylenol 1 & 2
Midrin Vanquish
(Sedatives)
Darvon Periactn
Dilantin Pherergan
Fiornal Seconal
Inderal Triavil
Librium Valium
Mepergan (fortis) Vistaril
(Vasoconstrictors)
Bellegal Ergostat
Cafergot (Cafregon) Gynergen
Ergotrate
(Analgesics)
Codeine
or other medication with codeine
examples: Emperin, Mepergan,
Percogesics, Phenergan and
Tylenol 3 s  & 4 s .
Leratine
Ponstel
Talwin
5 Demerol
6 Dilaudid
7 Morphine
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